AQR CAPITAL MANAGEMENT LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 1167557
Greenwich, CT
Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$111,403
New position
Shares Held
26,716
first reported quarter
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $2,674,320,731 across 76 Medical Devices names. CATX ranks #74 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,598,724 | $335,476,239 | |
| 2 | BSX |
Boston Scientific Corp
|
5,239,836 | $328,799,705 | |
| 3 | SYK |
Stryker Corp
|
972,085 | $319,417,404 | |
| 4 | STE |
STERIS plc
|
1,061,400 | $234,707,378 | |
| 5 | HAE |
Haemonetics Corp
|
3,356,543 | $189,174,760 | |
| 6 | ABT |
Abbott Laboratories
|
1,573,036 | $161,503,601 | |
| 7 | LIVN |
LivaNova PLC
|
2,494,372 | $158,542,282 | |
| 8 | EW |
Edwards Lifesciences Corp
|
1,968,753 | $157,657,737 |
All Filings in CATX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $111,403 | 26,716 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||